United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - methimazole (unii: 554z48xn5e) (methimazole - unii:554z48xn5e) - methimazole 5 mg - tapazole is indicated: - in patients with graves' disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy. tapazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.

Canada - English - Health Canada

paladin labs inc. - methimazole - tablet - 5mg - methimazole 5mg - antithyroid agents

Canada - English - Health Canada

paladin labs inc. - methimazole - tablet - 10mg - methimazole 10mg - antithyroid agents

Canada - English - Health Canada

paladin labs inc. - methimazole - tablet - 20mg - methimazole 20mg - antithyroid agents

Australia - English - Department of Health (Therapeutic Goods Administration)

evolutis ma australia pty ltd - 60516 - metallic acetabulum prosthesis - the capitole c cemented dual mobility cup is made from stainless steel intended to be cemented into the acetabulum. a removable mobile polyethylene liner is intended to be articulated with a constrained joint with a ball head of a femoral prosthesis. it may be used in association with cemented or cementless femoral stems and 22.2 or 28mm femoral head manufactured by evolutis. device indicated for the treatment of symptomatic pain and/or functional problems of the hip in patients whose skeleton is mature and only when pain killer medicamentation and correctly followed conservative treatment have failed. for the patient, his anatomy and the structure of his articulation will need to be adapted to receive the selected implant(s). indications for total or partial hip arthroplasty are: - degenerative non inflammatory hip disease (coxarthrosis, arthritis of the hip). - inflammatory hip disease (rheumatoid arthritis, post traumatic arthritis). - metabolic hip disease (chondrocalcinosis). - post traumatic degenerative arthritis. - avascular necrosis. - congenital dysplasia of the hip. - functional repair of a recent trauma (fracture, dislocation) - revision of a failed conservative surgery, osteosynthesis, partial or total arthroplasty. - tumoral surgery when affecting the hip joint. the recommended indications for dual mobility cup are: - primary arthroplasties for patients at high risk of dislocation (severe neurological affliction, neuropsychiatric disorders, addictions and severe neuromuscular deficiencies), - revision arthroplasties in cases of recurrent dislocations for patients at high risk of articular instability.

United States - English - NLM (National Library of Medicine)

certus pharma s.a. de c.v. - pyrethrum extract (pyrethrins) 0.17% piperonyl butoxide 2%, pediculicide - treats head, pubic (crab), and body lice